Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.QRxPharma Reports MoxDuo CR Phase 1 Trial Positive Results
The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood. The Phase 1 trial,
The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood. The Phase 1 trial,
The current data suggest that VB-201 has anti-inflammatory properties that are active against psoriasis; an ongoing Phase 2 efficacy and safety study is currently evaluating VB-201 for the
Evotec is expected to apply its integrated and innovative drug discovery platform in combination with its disease biology expertise against targets nominated by Genentech. This will include assay
NVA237 was licensed to Novartis by Sosei and its co-development partner Vectura Group in a 2005 deal in which the two companies could receive up to $375m in
The document is designed as an aid to laboratory and facility management to simplify and facilitate the selection process but also allows evaluation of devices to identify those
Janssen Pharma had launched Velcade in Japan in 2006, where it is approved for relapsed multiple myeloma. Velcade is currently approved in more than 90 countries and has
Halozyme has posted a net loss of $11.8m for the first quarter 2010, or $ 0.13 per diluted share, compared to $14.7m, or $ 0.18 per diluted share,
Osiris Therapeutics has posted a net income of $2.4m for the first quarter of 2010, or $0.07 per diluted share, compared to $14.7m, or $0.45 per diluted share,
QuantRx (QN Diagnostics) claimed that this is the first distribution agreement for the company in the animal healthcare market and marks the commercial launch of its first product
Intellipharmaceutics’ application will now proceed to full review by the FDA. Intellipharmaceutics aims to develop its pipeline products to an advanced stage, and will now seek a commercialization